Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic Portal Vein Thrombosis in HCV Related Compensated Cirrhosis
Phase of Trial: Phase III
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thrombosis
- Focus Therapeutic Use
- 26 Jun 2017 Planned End Date changed from 1 Dec 2020 to 1 Dec 2017.
- 26 Jun 2017 Planned primary completion date changed from 1 Dec 2020 to 1 Jul 2017.
- 22 Jun 2017 New trial record